Encompass Health Co. Expected to Post Q1 2025 Earnings of $1.13 Per Share (NYSE:EHC)

Encompass Health Co. (NYSE:EHCFree Report) – Investment analysts at Zacks Research raised their Q1 2025 EPS estimates for Encompass Health in a report released on Wednesday, May 8th. Zacks Research analyst Z. Masood now expects that the company will earn $1.13 per share for the quarter, up from their prior estimate of $1.07. The consensus estimate for Encompass Health’s current full-year earnings is $4.09 per share. Zacks Research also issued estimates for Encompass Health’s Q3 2025 earnings at $1.04 EPS.

Encompass Health (NYSE:EHCGet Free Report) last issued its earnings results on Wednesday, April 24th. The company reported $1.12 earnings per share for the quarter, topping analysts’ consensus estimates of $0.93 by $0.19. Encompass Health had a net margin of 7.60% and a return on equity of 18.01%. The firm had revenue of $1.32 billion during the quarter, compared to analyst estimates of $1.27 billion. During the same quarter in the prior year, the business earned $0.88 earnings per share. Encompass Health’s revenue for the quarter was up 13.4% on a year-over-year basis.

Other equities analysts have also issued research reports about the stock. Barclays increased their price objective on shares of Encompass Health from $101.00 to $108.00 and gave the company an “overweight” rating in a research report on Thursday, April 25th. Truist Financial increased their price objective on shares of Encompass Health from $82.00 to $86.00 and gave the company a “buy” rating in a research report on Friday, February 9th. Raymond James reiterated a “strong-buy” rating and set a $95.00 price objective (up previously from $85.00) on shares of Encompass Health in a research report on Friday, April 26th. Stephens reiterated an “overweight” rating and set a $85.00 price objective on shares of Encompass Health in a research report on Tuesday, January 16th. Finally, William Blair reissued an “outperform” rating on shares of Encompass Health in a research note on Wednesday, February 7th. Eight investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of $90.29.

Get Our Latest Stock Report on Encompass Health

Encompass Health Price Performance

EHC stock opened at $86.87 on Monday. Encompass Health has a 52 week low of $57.55 and a 52 week high of $87.04. The company has a quick ratio of 1.37, a current ratio of 1.37 and a debt-to-equity ratio of 1.14. The company has a fifty day simple moving average of $80.71 and a two-hundred day simple moving average of $72.82. The firm has a market capitalization of $8.75 billion, a P/E ratio of 23.48, a price-to-earnings-growth ratio of 1.35 and a beta of 0.92.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, July 15th. Investors of record on Monday, July 1st will be paid a $0.15 dividend. This represents a $0.60 annualized dividend and a yield of 0.69%. The ex-dividend date is Friday, June 28th. Encompass Health’s dividend payout ratio is presently 16.22%.

Insider Buying and Selling

In related news, EVP John Patrick Darby sold 14,543 shares of the firm’s stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $83.94, for a total value of $1,220,739.42. Following the transaction, the executive vice president now owns 84,773 shares of the company’s stock, valued at approximately $7,115,845.62. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other Encompass Health news, CEO Mark J. Tarr sold 44,976 shares of the firm’s stock in a transaction dated Tuesday, April 30th. The shares were sold at an average price of $83.27, for a total transaction of $3,745,151.52. Following the transaction, the chief executive officer now owns 554,098 shares of the company’s stock, valued at approximately $46,139,740.46. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP John Patrick Darby sold 14,543 shares of the firm’s stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $83.94, for a total transaction of $1,220,739.42. Following the transaction, the executive vice president now directly owns 84,773 shares in the company, valued at approximately $7,115,845.62. The disclosure for this sale can be found here. 2.10% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. Principal Securities Inc. purchased a new position in Encompass Health during the 4th quarter valued at about $25,000. Benjamin F. Edwards & Company Inc. increased its position in Encompass Health by 360.2% during the 4th quarter. Benjamin F. Edwards & Company Inc. now owns 405 shares of the company’s stock valued at $27,000 after purchasing an additional 317 shares during the period. McGlone Suttner Wealth Management Inc. bought a new stake in shares of Encompass Health in the 4th quarter valued at about $30,000. GAMMA Investing LLC bought a new stake in shares of Encompass Health in the 4th quarter valued at about $33,000. Finally, C M Bidwell & Associates Ltd. bought a new stake in shares of Encompass Health in the 3rd quarter valued at about $35,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

About Encompass Health

(Get Free Report)

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

Recommended Stories

Earnings History and Estimates for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.